The explicit permission to sell Ekso Bionics suggests management is actively pursuing a divestiture. Monitor for a subsequent 8-K announcing a definitive agreement to sell Ekso Bionics, which would provide cash proceeds and potentially simplify the corporate structure.
Price Chart
Executive Summary
ChronoScale Holdings amended its secured promissory note with B. Riley Commercial Capital, extending the maturity date from September 12, 2026 to November 12, 2026, and explicitly permitting the sale of its subsidiary Ekso Bionics, Inc. (the Guarantor) without triggering a default or change of control. The $2.0 million term loan remains outstanding and the amendment clears a path for a potential divestiture of Ekso Bionics.
Key Facts
- Maturity date extended from September 12, 2026 to November 12, 2026.
- $2.0 million aggregate principal amount remains outstanding under the term loan.
- Sale of Ekso Bionics, Inc. (the Guarantor) is now a 'Permitted Disposition' under the note, not a Change of Control.
- Lender's liens on assets/capital stock sold in a Permitted Disposition will be automatically released without payment.
- Amendment executed September 12, 2026; filing date September 16, 2026.
Financial Impact
No new capital raised. $2.0 million term loan extended by 2 months. The amendment removes a contractual barrier to selling Ekso Bionics, but no sale has been announced or valued.
Risk Factors
- The $2.0 million term loan matures in less than 2 months (November 12, 2026), creating near-term refinancing risk if the Ekso sale does not close.
- No buyer or valuation for Ekso Bionics has been disclosed; the sale may not materialize or may be at an unfavorable price.
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-042947 |
| Exhibit: ex10-1.htm | 0001493152-26-042947 |
| Document: 0001493152-26-042947-index-headers.html | 0001493152-26-042947 |
| Document: 0001493152-26-042947-index.html | 0001493152-26-042947 |
| Document: 0001493152-26-042947.txt | 0001493152-26-042947 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 11d ago | DEFA14A | $14.97 $15.76 | ▲ +5.28% | ▲ +4.94% | $17.49 (+16.83%) |
Oct 15, 2026 12d ago | 8-K | $15.08 $14.97 | ▼ −0.73% | ▼ −1.15% | $17.49 (+15.98%) |
Oct 15, 2026 12d ago | Press Release | $15.08 $14.97 | ▼ −0.73% | ▼ −1.15% | $17.49 (+15.98%) |
Oct 13, 2026 14d ago | EFFECT | $16.31 $14.88 | ▲ +8.77% | ▲ +7.69% | $17.49 (−7.23%) |
Oct 6, 2026 21d ago | 8-K | $19.77 $19.03 | ▼ −3.74% | ▼ −3.32% | $17.49 (−11.53%) |
Oct 6, 2026 21d ago | S-3 | $19.77 $19.03 | ▼ −3.74% | ▼ −3.32% | $17.49 (−11.53%) |
Oct 2, 2026 25d ago | 8-K | $18.60 $19.28 | ▲ +3.66% | ▲ +3.11% | $17.49 (−5.97%) |
Oct 1, 2026 26d ago | Press Release | $19.21 $18.60 | ▼ −3.18% | ▼ −3.85% | $17.49 (−8.95%) |
Sep 25, 2026 4w ago | DEFA14A | $19.82 $19.75 | ▼ −0.33% | ▼ −0.14% | $17.49 (−11.73%) |
Sep 25, 2026 4w ago | DEF 14A | $19.82 $19.75 | ▼ −0.33% | ▼ −0.14% | $17.49 (−11.73%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers